Opposite effects of iv amiodarone on cardiovascular vagal and sympathetic efferent activities in rats

被引:22
作者
Da Silva, VJD
Gnecchi-Ruscone, T
Lavelli, B
Bellina, V
Manzella, D
Porta, A
Malliani, A
Montano, N
机构
[1] Univ Milan, Osped L Sacco, LITA Vialba, Dipartimento Sci Preclin, I-20157 Milan, Italy
[2] Osped SL Mandic, Div Cardiol, I-22055 Merate, LC, Italy
[3] Univ Naples 2, Dipartimento Geriatria & Malattie Metab, Naples, Italy
[4] Sch Med Triangulo Mineiro, Dept Biol Sci, BR-38015050 Uberaba, Brazil
关键词
arrhythmias; autonomic nervous system; baroreceptors; heart rate;
D O I
10.1152/ajpregu.00608.2001
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
It is unknown whether amiodarone exerts a direct central action on the cardiovascular autonomic nervous system. This study was designed to evaluate the effects of acute amiodarone administration on vagal and sympathetic efferent nerve discharges. Experiments were carried out in 25 decerebrate unanesthetized rats. In one group, vagal activity was recorded from preganglionic fibers isolated from the cervical vagus nerve. In another group, sympathetic recordings were obtained from fibers isolated from the cervical sympathetic trunk in intact conditions or after barodenervation. Recordings were performed before and for 60 min after amiodarone (50 mg/kg iv) administration. In all groups, amiodarone induced bradycardia and hypotension. Vagal activity increased immediately, reaching a significant difference after 20 min (260+/-131% from 16.4+/-3.3 spikes/s) and was unmodified by the barodenervation. At difference, sympathetic activity after an initial and short-lasting increase (150+/-83% from 24.8+/-5.7 spikes/s) began to decrease significantly after 20 min (36+/-17%) throughout the experiment. The initial increase in sympathetic activity was not observed in barodenervated animals. These changes in vagal and sympathetic activity could play an important role in contributing to the antiarrhythmic action of amiodarone.
引用
收藏
页码:R543 / R548
页数:6
相关论文
共 26 条
[1]   EFFECTS OF AMIODARONE], AN ALPHA-RECEPTOR AND BETA-RECEPTOR ANTAGONIST, ON ADRENERGIC TRANSMISSION IN CAT SPLEEN [J].
BACQ, ZM ;
BLAKELEY, AGH ;
SUMMERS, RJ .
BIOCHEMICAL PHARMACOLOGY, 1976, 25 (10) :1195-1199
[2]  
*CARD ARRH SUPPR T, 1991, NEW ENGL J MED, V327, P227
[3]   SINGLE CARDIAC VAGAL FIBER ACTIVITY, ACUTE MYOCARDIAL-ISCHEMIA, AND RISK FOR SUDDEN-DEATH [J].
CERATI, D ;
SCHWARTZ, PJ .
CIRCULATION RESEARCH, 1991, 69 (05) :1389-1401
[4]  
COHEN-ARMON M, 1984, J CARDIOVASC PHARM, V6, P1148
[5]  
Connolly SJ, 1997, LANCET, V350, P1417
[6]   Evidence-based analysis of amiodarone efficacy and safety [J].
Connolly, SJ .
CIRCULATION, 1999, 100 (19) :2025-2034
[7]   Autonomic influences in atrial tachyarrhythmias [J].
Coumel, P .
JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 1996, 7 (10) :999-1007
[8]  
da Silva VJD, 2000, FASEB J, V14, pA56
[9]   SYMPATHOLYTIC ACTION OF INTRAVENOUS AMIODARONE IN THE RAT-HEART [J].
DU, XJ ;
ESLER, MD ;
DART, AM .
CIRCULATION, 1995, 91 (02) :462-470
[10]   MORTALITY AND MORBIDITY IN PATIENTS RECEIVING ENCAINIDE, FLECAINIDE, OR PLACEBO - THE CARDIAC-ARRHYTHMIA SUPPRESSION TRIAL [J].
ECHT, DS ;
LIEBSON, PR ;
MITCHELL, LB ;
PETERS, RW ;
OBIASMANNO, D ;
BARKER, AH ;
ARENSBERG, D ;
BAKER, A ;
FRIEDMAN, L ;
GREENE, HL ;
HUTHER, ML ;
RICHARDSON, DW .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (12) :781-788